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1. Introduction
  NDGR2 is a newly discovered gene that can be harvested 
from human brain tissue by clone technology and contains 
an acyl carrier protein-like domain[1]. NDRG2 expression 
differs between tumor and normal tissues. Generally, its 
expression level is positively correlated with the degree of 
organ development and its expression state is negatively 
correlated with the proliferative capacity of cells[2-4]. 
NDRG2 is related to cell proliferation and differentiation 
and plays a remarkable inhibitory role in tumor occurrence 
and development in diverse systems including aspiratory, 
digestive and nervous systems[5-8]. The occurrence and 
development of renal cell carcinoma correlate various 
factors, and activation of anti-oncogene is one of the most 
important factors[9-11]. This study established NDRG2-
transfected OS-RC-2-GFP-NDRG2 cell strains and 
investigated the inhibitory effects of NDRG2 on OS-RC-2 
cell growth and proliferation and the possible underlying 
mechanism. 
2. Materials and methods 
2.1. Materials 
  1640 culture medium was purchased from Gibco (New 
York, NY, USA). Trypsin-ethylenediamine tetraacetic 
acid (EDTA), MTT, and dimethyl sulfoxide (DMSO) were 
purchased from Sigma (St. Louis, MO, USA). Fetal bovine 
serum (FBS) was from Zhejiang Tianhang Biological 
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Technology Co., Ltd., China (Hangzhou, Zhejiang Province, 
China). Human renal cell carcinoma cell line OS-RC-2 was 
purchased from Cell Bank, Chinese Academy of Sciences, 
China. Recombinant human NDRG2 adenovirus was packed 
and identified by Cyagen Biosciences Co., Ltd., (Guangzhou, 
Guangdong Province, China). Mouse anti-human NDRG2 
antibody was purchased from Abcam(HK)Ltd (Hong Kong, 
China). Rabbit anti-mouse antibody was from Kangchen 
Biological Co., Ltd., (Shanghai, China).  
2.2. Construction of pAV.EX1d-NDRG2 /IRES/eGFP 
adenovirus plasmid 
  The gene product attB1-Kozak-SYLD/IRES/eGFP-attB2 
was amplified by PCR. The primer and sequence used were 
as follows.
Primer Sequence (5’-3’)
attB1-K-SYLD GGGGACAAGTTTGTACAAAAAAGCAGGCT
GCCACCATGGCGGAGCTGCAGGAG
SYLD-IRES-R GGGGGAGGGAGAGGGGCTCAACAGGAGAC
CTCCATGG
IRES/EGFP-F GCCCCTCTCCCTCCCCC
attB2-EGFP-R GGGGACCACTTTGTACAAGAAAGCTGGGTT
TACTTGTACAGCTCGTCCATG
    pDown-SYLD/IRES/eGFP and pAV.EX1d-SYLD/IRES/
eGFP plasmids were constructed by Gateway Technology. 
pDown-SYLD/IRES/eGFP and pAV. Des1d plasmid DNA 
was extracted. After sequencing, adenovirus plasmids with 
correct sequences were packaged, amplified and condensed, 
and finally virus titer was determined. 
2.3. Adenovirus transfection 
  On day 2 after cell inoculation, adenovirus transfection 
was performed when cells reached 30%-40% confluence. 
Before transfection, cells in each well were treated with 
1 mL fresh 1640 culture medium plus 10% FBS. A 10-
mL aliquot of adenovirus I carrying NDRG2 and GFP gene 
was separately added to one well from each of two 6-well 
plates and a 10-mL aliquot of adenovirus II carrying GFP 
gene was added to another well from each plate. After 
fully mixed, the resultant sample was incubated in a 5% 
CO2, 95% relative humidity environment at 37 曟 for 16 
hours. After getting rid of adenovirus-containing complete 
medium, cells were washed twice with PBS and treated with 
fresh 1640 culture medium plus 10% FBS in a 5% CO2, 95% 
relative humidity environment at 37 曟 for 48 hours. Finally, 
cells were observed under a fluorescence microscope and 
photographed. 
2.4. Western blot analysis[12] 
  After 48 hour transfection, total protein was extracted 
from cells in each group and quantified according to the 
method recommended by protein quantification kit. Briefly, 
100 毺g protein sample was subjected to SDS-PAGE and 
electrically transferred onto a nitrocellulose membrane at 
300 mA. Seventy minutes later, the sample was blocked 
with 5% defatted milk for 1 hour at room temperature 
and treated with mouse anti-human NDRG2 (at 1:1 200 
dilution) at 4 曟 overnight, washed with TBST, blocked 
with rabbit anti-mouse antibody (at proper dilution) for 
1 hour at room temperature, and developed by enhanced 
chemiluminescence method. Finally, it was observed 
through the use of FluorChem HD2 gel image system and 
photographed.   
2.5. Cell proliferation detection[13,14] 
  When cells reached 80%-90% confluence, they were 
trypsinized. Cell suspension was diluted by gradient method 
and cells were counted. 500 OS-RC-2-GFP-NDRG2, OS-
RC-2-GFP or OS-RC-2 cells were seeded into a 100-
mm-sized culture dish, treated with 15 mL of 1640 culture 
medium plus 10% FBS in a 5% CO2 incubator at 37 曟. The 
culture medium was renewed every 3 days. Thirteen days 
later, cells were stained with Giemsa dye, fixed, cloned and 
counted. 
  When cells were 80%-90% confluent, they were trypsinized, 
counted and seeded into a 96-well plate at a density of 2伊103 
cells/well. Five parallel wells were designated for each cell 
strain. Each cell strain was seeded into 35 wells. Seven 96-
well plates were used. After addition of 200 毺L 1640 culture 
medium plus 10% FBS to each well, cells were incubated in a 
5% CO2 incubator at 37 曟. Day 1 was designated for 24 hours 
after inoculation. On each day after inoculation (total 7 days), 
one 96-well plate was taken for determination of absorbance 
value using MTT assay.
2.6. Cell cycle analysis[15] 
  Cells were trypsinized when they reached 80%-90% 
confluence. After centrifugation at 244 伊 g for 4 minutes, 
the supernatant was discarded. After one wash with ice-
cold PBS, cells were re-suspended with 200 毺L ice-cold 
PBS, and ice-cold 70% ethanol was added in a drop-wise 
manner while shaking gently. Samples were fixed at 4 曟 
for a minimum of 6 hours or at -20 曟 till use. Following 
centrifugation at 250 伊 g for 4 minutes, the supernatant 
was carefully discarded and cells were re-suspended 
with 1-2 mL ice-cold PBS to get rid of the fixing solution. 
After addition of 500 毺L of PBS containing 100 毺g/mL 
RNase, cells were incubated at 37 曟 for 0.5-1 hour. After 
addition of 500 毺L of PBS containing 50 毺g/mL PI and 
0.2% Triton X-100, cells were incubated in the dark at 4 曟 
for 20-30 minutes. Centrifugation and supernatant removal 
were performed before incubation. Finally, cells were re-
suspended with 300-400 毺L PBS. Cell cycle was determined 
by flow cytometry. The percentage of cells in G1, G2 and S 
phases was calculated. 
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2.7. Observation of subcellular localization of NDRG2 protein 
by confocal laser scanning microscopy
  Cells were trypsinized when they reached 80%-90% 
confluence. The cells were seeded onto the slide placed in 
the well of 96-well plate at a density of 5伊104-5伊105 cells/
mL and incubated with culture medium. After 6, 16, 24, 48 
and 72 hours of incubation, culture medium was discarded 
and cells were further incubated for 30-60 minutes with 
Rhodamine 123 working solution (probe for mitochondrion). 
The slide was taken out, enveloped with glycerine, 
observed under confocal laser scanning microscope, and 
photographed. Subcellular localization of NDRG2 protein was 
observed using the same method with boron dipyrromethene 
(probe for Golgi apparatus) and Lucifer yellow (probe for 
lysosome). 
3. Results 
3.1. Specifically expression of NDRG2 protein in OS-RC-2-
GFP-NDRG2 cells after adenovirus transfection
  After adenovirus transfection for 48 hours, NDRG2 protein 
expression in cells was detected by western blot analysis. 
NDRG2 protein expression was present in neither OS-RC-2 
nor OS-RC-2-GFP cells. While significant NDRG2 protein 
expression was detected in OS-RC-2-GFP-NDRG2 cells 
(Figure 1). 
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Figure 1. NDRG2 protein expression in OS-RC-2-GFP-NDRG2, 
OS-RC-2-GFP and OS-RC-2 cells. 
(A) Western blot analysis. (B) Quantification results by analysis 
software. Values are expressed as mean±SEM. **P<0.01, vs. OS-RC-
2-GFP-NDRG2 cells. 
3.2. Biological characteristics of OS-RC-2-GFP-NDRG2 
cells 
  After adenovirus transfection for 48 hours, cell growth 
was observed through the use of light and fluorescence 
microscopes[16,17]. After transfection, approximately 100% 
of OS-RC-2-GFP cells exhibited green fluorescence, with 
slight atrophy symptom, and approximately 60% of OS-RC-
2-GFP-NDRG2 cells exhibited green fluorescence, with 
more obvious atrophy symptom (Figure 2).
A    OS-RC-2-GFP, 4S h-200伊              B  OS-RC-2-GFP-SYLK, 48 h-200伊
 
 
Figure 2. Effects of adenovirus-mediated GFP gene (A) and GFP 
+ NDRG2 gene transfection for 48 hours on the growth state of OS-
RC-2 cells (B) as shown by light and fluorescence microscopes. 
3.3. Proliferation of OS-RC-2-GFP-NDRG2 cells after 
adenovirus transfection
  Colony-forming cell assay results showed that the colony-
forming efficiency of OS-RC-2-GFP-NDRG2 cells was 
significantly lower than that of OS-RC-2-GFP cells or OS-
RC-2 cells (24.8% vs. 51.65% or 76.4%). MTT assay showed 
that the proliferative capacity of OS-RC-2-GFP-NDRG2 
cells was significantly lower than that of OS-RC-2-GFP 
cells or OS-RC-2 cells (Figures 3, 4). 
OS-RC-2                          OS-RC-2-GFP              OS-RC-2-GFP-SYLDA
Cells
Numbers of cloning cells 
(n)
Cloning efficiency 
(numbers/500 cells)
OS-RC-2 382 76.4%
OS-RC-2-GFP 258 51.6%
OS-RC-2-GFP-SYLD 124 24.8%*
Cloning efficiency of cellsB
Figure 3. Effect of NDRG2 transfection on proliferation of OS-RC-2 
cells. 
(A) Colony-forming cell assay results. (B) Calculation of colony-
forming efficiency of OS-RC-2, OS-RC-2-GFP and OS-RC-2-
GFP-NDRG2 cells. The colony-forming efficiency=number of cloned 
cells /500 cells 伊100%. *P<0.01, vs. OS-RC-2 cells. 
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Figure 4. Growth curves of OS-RC-2, OS-RC-2-GFP and OS-RC-
2-GFP-NDRG2 cells. 
Absorbance (OD) value at 490 nm of each kind of cells at different 
time points was determined by MTT assay. Cell growth curves were 
plotted. Values are expressed as mean暲SEM. **P<0.01, vs. OS-
RC-2 cells. 
3.4. Determination of cell cycle by flow cytometry 
  Flow cytometry results showed that after adenovirus 
transfection, the number of cells in S phase was significantly 
increased (P<0.05), while the number of cells in G2M and 
G0G1 phases was significantly decreased in the OS-RC-2-
GFP-NDRG2 group than in the OS-RC-2 group, and cells 
were arrested in S phase, but peak of cell apoptosis was not 
observed (Figure 5).
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Figure 5. Effects of adenovirus-mediated NDRG2 transfection on cell 
cycle. 
(A) Cell cycle of OS-RC-2-GFP-NDRG2 cells. (B) Cell cycle of OS-
RC-2-GFP cells. (C) Cell cycle of OS-RC-2 cells. (D) Cell cycle 
analysis by ModFit software. All measurements were repeated three 
times. Data were expressed as mean暲SEM. *P<0.05, vs. OS-RC-2 
ells. 
3.5. NDRG2 protein was specifically expressed in the 
mitochondrion of OS-RC-2-GFP-NDRG2 cells 
  Confocal laser scanning microscopy results showed 
that NDRG2 protein was specifically expressed in the 
mitochondrion of OS-RC-2-GFP-NDRG2 cells and its 
expression was gradually increased with time (Figure 6), 
and this protein was not detected in the lysosome or Golgi 
apparatus. 
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Figure 6. Subcellular location of immunofluorescence in OS-RC-2-
GFP-NDRG2 cells. 
(A) Mitochondrial location of immunofluorescence at different time 
points. (B) Mean fluorescent intensity (MFI) value analysis using 
image process software. Data are expressed as mean±SEM.  
4. Discussion
  There is strong evidence that NDRG2 gene is related to 
cell growth, differentiation, apoptosis, stress reaction, 
histogenesis and organ formation[18-21]. Previous histological 
findings have demonstrated that NDRG2 expression differs 
in diverse tumor tissues, including liver cancer, breast 
cancer, colon cancer and prostate cancer tissues[22-24]. All 
these suggest that NDRG2, likely as an anti-oncogene, 
participates in tumor occurrence, development and turnover. 
This study investigated the effects of adenovirus-
mediated exogenous NDRG2 transfection on the biological 
characteristics of OS-RC-2 cells. Results showed that after 
transfection, NDRG2 protein was specifically expressed 
in OS-RC-2-GFP-NDRG2 cells rather than in OS-RC-2 
cells or OS-RC-2-GFP cells. These findings demonstrate 
that NDRG2 gene can be highly transfected into OS-RC-2 
cells by adenovirus mediation. Results also showed that 
after transfection, approximately 100% of OS-RC-2-GFP 
cells exhibited fluorescence, with nearly unchangeable 
morphology, however, about 60% of OS-RC-2-GFP-
NDRG2 cells exhibited fluorescence, with obvious atrophic 
morphology. This suggests that NDRG2 gene transfection 
significantly inhibits the growth of OS-RC-2 cells. 
  This study investigated the proliferation and growth of 
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NDRG2-expressing cells by colony-forming cell assay 
and MTT assay. Colony-forming cell assay showed that the 
colony-forming efficiency of OS-RC-2-GFP-NDRG2 cells 
was significantly decreased than that of OS-RC-2 and OS-
RC-2-GFP cells. MTT assay showed that the growth of OS-
RC-2-GFP-NDRG2 cells was significantly inhibited. These 
findings suggest that NDRG2 transfection can significantly 
inhibit the proliferation and growth of OS-RC-2 cells. 
This study determined cell cycle using flow cytometry to 
investigate the inhibitory effects of NDRG2 transfection 
on cell proliferation. The number of cells in S phase was 
significantly increased, while that in G2M and G0G1 phases 
was significantly decreased in the OS-RC-2-GFP-NDRG2 
group than in the OS-RC-2 group. But the peak of cell 
apoptosis was not observed in S phase in the OS-RC-2-
GFP-NDRG2 group. S phase of cell cycle is an important 
period for cellular DNA replication and enzyme synthesis. 
Cells were arrested in S phase, which influences cells entry 
into G2 phase, subsequent DNA replication and mitosis, and 
final cell proliferation
  To preliminarily investigate the possible mechanism 
by which NDRG2 gene inhibits cell proliferation, we 
performed subcellular location of NDGR2 protein by 
immunofluorescence staining. Confocal laser scanning 
microscopy results showed that NDRG2 protein was mainly 
expressed, and gradually increased with time, in the 
mitochondrion of OS-RC-2-GFP-NDRG2 cells, however, 
its expression was not present in the lysosome or Golgi 
apparatus. The mitochondrion is a special organelle that 
exists in the cytoplasm of the eukaryocytes and plays an 
important role in cell energy metabolism, oxygen free radical 
generation, aging, and apoptosis[25-28]. Most ATP production 
relies on oxidative phosphorylation in normal cells and on 
glycolytic pathway in tumor cells. 
  ATP-synthesizing enzyme subunit B expression is 
significantly decreased in the mitochondrial inner 
membrane in the majority of tumor cells. Any factors that 
can decease mitochondrial oxidative phosphorylation are 
related to the rapid growth and the increasing invasion 
of tumor cells[29]. Therefore, interfering mitochondrial 
function in tumor cells is likely to play an inhibitory 
effect on tumor cell growth and invasion. In addition, an 
important pathway by which mitochondrion participants in 
tumor cell toxicity is to increase intracellular oxygen free 
radical generation, because which can injury or decrease 
mitochondrial membrane potential and lead to release 
of cytochrome C and apoptosis inducing factors[30,31]. 
Results from this study showed that NDRG2 is specifically 
expressed in the mitochondrion of OS-RC-2-GFP-NDRG2 
cells. This suggests that the inhibitory effect of NDRG2 
on cell proliferation is accomplished via intracellular 
mitochondrion. However, no obvious apoptosis was detected 
by flow cytometry. This suggests that NDRG2 inhibits OS-
RC-2 cell proliferation not through initiating apoptosis, 
which is different from previous findings[32,33]. Thus, it is 
presumed that NDRG2 inhibits the proliferation of OS-
RC-2 cells possibly through inhibiting mitochondrial ATP-
synthesizing enzyme generation and interfering the activity 
of mitochondrial NADH CoQ reductase or through inhibiting 
the function of mitochondrial inner membrane-bound 
protein and inhibiting mitochondrial respiratory function 
and energy metabolism. The precise mechanism needs to be 
further investigated. 
  Taken together, NDRG2 has an obvious inhibitory effect on 
the proliferation of human renal cancer OS-RC-2 cells and 
its protein is specifically expressed in the mitochondrion 
of OS-RC-2 cells. This provides a novel clue for studying 
the pathological mechanism underlying renal cancer and 
also suggests that NDRG2 likely regulates the growth of 
renal cancer cells and becomes a novel target for gene 
therapy of renal cancer. Nevertheless, some uncertainties 
need to be further investigated, including the precise 
mitochondrion related mechanism by which NDGR2 inhibits 
the proliferation of OS-RC-2 cells and the effect of NDGR2 
gene on biological characteristics of OS-RC-2 cells in vivo. 
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